Most Read

  • 21 May 2019

    The top selling prescription drugs by revenue

    Humira tops the list despite growing biosimilar competition, while Opdivo and Keytruda, the new-age checkpoint inhibitors for cancer have grown in terms of market share and revenue generation since their...

  • 21 November 2018

    Pharma Technology Focus – Issue 77

    In this issue: China’s growing pharmaceutical market, antimicrobial resistance, the rise of tech giants in healthcare, and more.

  • 20 September 2018

    Pharma Technology Focus – Issue 75

    In this issue: Making manufacturing work in gene and cell therapies, AI generated compounds, clinical trial transparency in the Americas, and more.

  • 19 July 2018

    Pharma Technology Focus – Issue 73

    In this issue: Major investment signals confidence in the search for new products developed from DNA found in soil, a medical milestone for cannabinoids in the US, streamlining clinical research,...

  • 27 June 2018

    Pharma Technology Focus – Issue 72

    In this issue: Overcoming red tape in China, how to boost adoption of biosimilars in the US, a profile of global health research network TriNetX, unlocking cell-free protein synthesis, and...

  • 27 February 2018

    Pharma Technology Focus – Issue 68

    In this issue: The benefits of seamless clinical trials, a new functional cure for HIV, using mRNA to target cancer tumours, the potential of magnetic hyperthermia in killing cancerous cells,...

  • 24 January 2018

    Pharma Technology Focus – Issue 67

    In this issue: How cancer drug resistance works, accessing funding for rare diseases, India’s attempt to redefine over the counter drugs, the biotech potential of slipper limpets, Dundee University’s influence...

Close
Close
Close